355 related articles for article (PubMed ID: 16973241)
21. Molecular genetics of Alzheimer's disease: what have we learned?
Van Gassen G; Van Broeckhoven C
Acta Neurol Belg; 2000 Jun; 100(2):65-76. PubMed ID: 10934557
[TBL] [Abstract][Full Text] [Related]
22. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
[TBL] [Abstract][Full Text] [Related]
23. Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced Abeta levels in cellular models of Alzheimer's disease.
Sahlin C; Pettersson FE; Nilsson LN; Lannfelt L; Johansson AS
Eur J Neurosci; 2007 Aug; 26(4):882-9. PubMed ID: 17714184
[TBL] [Abstract][Full Text] [Related]
24. Embryonic stem cell-derived neurons as a cellular system to study gene function: lack of amyloid precursor proteins APP and APLP2 leads to defective synaptic transmission.
Schrenk-Siemens K; Perez-Alcala S; Richter J; Lacroix E; Rahuel J; Korte M; Müller U; Barde YA; Bibel M
Stem Cells; 2008 Aug; 26(8):2153-63. PubMed ID: 18535156
[TBL] [Abstract][Full Text] [Related]
25. Neurosecretases provide strategies to treat sporadic and familial Alzheimer disorders.
Marks N; Berg MJ
Neurochem Int; 2008 Jan; 52(1-2):184-215. PubMed ID: 17719698
[TBL] [Abstract][Full Text] [Related]
26. Regulation of gamma-secretase activity in Alzheimer's disease.
Zhou S; Zhou H; Walian PJ; Jap BK
Biochemistry; 2007 Mar; 46(10):2553-63. PubMed ID: 17298085
[TBL] [Abstract][Full Text] [Related]
27. Excess of nicastrin in brain results in heterozygosity having no effect on endogenous APP processing and amyloid peptide levels in vivo.
Brijbassi S; Amtul Z; Newbigging S; Westaway D; St George-Hyslop P; Rozmahel RF
Neurobiol Dis; 2007 Feb; 25(2):291-6. PubMed ID: 17071095
[TBL] [Abstract][Full Text] [Related]
28. A mutation screening by DHPLC of PSEN1 and APP genes reveals no significant variation associated with the sporadic late-onset form of Alzheimer's disease.
Scacchi R; Gambina G; Moretto G; Corbo RM
Neurosci Lett; 2007 May; 418(3):282-5. PubMed ID: 17412506
[TBL] [Abstract][Full Text] [Related]
29. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
[TBL] [Abstract][Full Text] [Related]
30. Polymorphism in genes involved in adrenergic signaling associated with Alzheimer's.
Bullido MJ; Ramos MC; Ruiz-Gómez A; Tutor AS; Sastre I; Frank A; Coria F; Gil P; Mayor F; Valdivieso F
Neurobiol Aging; 2004 Aug; 25(7):853-9. PubMed ID: 15212839
[TBL] [Abstract][Full Text] [Related]
31. Cholesterol homeostasis and the pathophysiology of Alzheimer's disease.
Blain JF; Poirier J
Expert Rev Neurother; 2004 Sep; 4(5):823-9. PubMed ID: 15853509
[TBL] [Abstract][Full Text] [Related]
32. The Alzheimer's disease-associated gamma-secretase complex: functional domains in the presenilin 1 protein.
Laudon H; Winblad B; Näslund J
Physiol Behav; 2007 Sep; 92(1-2):115-20. PubMed ID: 17588625
[TBL] [Abstract][Full Text] [Related]
33. Genomics and phenotypic profiles in dementia: implications for pharmacological treatment.
Cacabelos R; Fernández-Novoa L; Corzo L; Pichel V; Lombardi V; Kubota Y
Methods Find Exp Clin Pharmacol; 2004; 26(6):421-44. PubMed ID: 15349138
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
Rakover I; Arbel M; Solomon B
Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
[TBL] [Abstract][Full Text] [Related]
35. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses.
Bertram L; Tanzi RE
Nat Rev Neurosci; 2008 Oct; 9(10):768-78. PubMed ID: 18802446
[TBL] [Abstract][Full Text] [Related]
36. Rac1 changes the substrate specificity of gamma-secretase between amyloid precursor protein and Notch1.
Boo JH; Sohn JH; Kim JE; Song H; Mook-Jung I
Biochem Biophys Res Commun; 2008 Aug; 372(4):913-7. PubMed ID: 18538664
[TBL] [Abstract][Full Text] [Related]
37. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE
J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896
[TBL] [Abstract][Full Text] [Related]
38. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease.
Anandatheerthavarada HK; Devi L
Neuroscientist; 2007 Dec; 13(6):626-38. PubMed ID: 17911214
[TBL] [Abstract][Full Text] [Related]
39. [The transcription of the amyloid precursor protein and tryptophan 2,3-dioxygenase genes are increased by aging in the rat brain].
Kálmán S; Pákáski M; Szucs S; Garab D; Domokos A; Zvara A; Puskás L; Bagdy G; Zelena D; Kálmán J
Ideggyogy Sz; 2009 Sep; 62(9-10):326-32. PubMed ID: 19835274
[TBL] [Abstract][Full Text] [Related]
40. Swedish amyloid precursor protein mutation increases cell cycle-related proteins in vitro and in vivo.
Ahn KW; Joo Y; Choi Y; Kim M; Lee SH; Cha SH; Suh YH; Kim HS
J Neurosci Res; 2008 Aug; 86(11):2476-87. PubMed ID: 18438935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
